AU2001280908A1 - Rotavirus vaccine formulations - Google Patents
Rotavirus vaccine formulationsInfo
- Publication number
- AU2001280908A1 AU2001280908A1 AU2001280908A AU8090801A AU2001280908A1 AU 2001280908 A1 AU2001280908 A1 AU 2001280908A1 AU 2001280908 A AU2001280908 A AU 2001280908A AU 8090801 A AU8090801 A AU 8090801A AU 2001280908 A1 AU2001280908 A1 AU 2001280908A1
- Authority
- AU
- Australia
- Prior art keywords
- vaccine formulations
- rotavirus vaccine
- rotavirus
- formulations
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09631807 | 2000-08-03 | ||
US09/631,807 US6616931B1 (en) | 1996-09-26 | 2000-08-03 | Rotavirus vaccine formulations |
PCT/US2001/023926 WO2002011540A1 (en) | 2000-08-03 | 2001-07-20 | Rotavirus vaccine formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001280908A1 true AU2001280908A1 (en) | 2002-02-18 |
Family
ID=24532815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001280908A Abandoned AU2001280908A1 (en) | 2000-08-03 | 2001-07-20 | Rotavirus vaccine formulations |
Country Status (3)
Country | Link |
---|---|
US (1) | US6616931B1 (en) |
AU (1) | AU2001280908A1 (en) |
WO (1) | WO2002011540A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0503337D0 (en) * | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
CA2630349A1 (en) * | 2005-11-21 | 2007-05-24 | Sanofi Pasteur Limited | Stabilizing formulations for recombinant viruses |
EP2360175B1 (en) | 2005-11-22 | 2014-07-16 | Novartis Vaccines and Diagnostics, Inc. | Norovirus and Sapovirus virus-like particles (VLPs) |
AU2007251122B2 (en) * | 2006-05-12 | 2013-01-10 | Bharat Biotech International Limited | A composition useful as a vaccine |
CA2668417A1 (en) * | 2006-11-03 | 2008-05-15 | Alphavax, Inc. | Alphavirus and alphavirus replicon particle formulations and methods |
KR101562971B1 (en) | 2007-04-06 | 2015-10-23 | 다케다 백신즈 인코포레이티드 | Methods and compositions for live attenuated viruses |
US8241886B2 (en) * | 2007-09-25 | 2012-08-14 | Aridis Pharmaceuticals | Formulations for preservation of rotavirus |
CN102695522B (en) | 2009-05-12 | 2016-10-19 | 美国政府(由卫生和人类服务部、疾病控制和预防中心的部长所代表) | New Human reoviruslike agent strain and vaccine |
CN102470170B (en) * | 2009-07-13 | 2015-03-18 | 巴拉特生物技术国际有限公司 | Composition useful as rotavirus vaccine and a method therefor |
US20130028933A1 (en) * | 2009-12-28 | 2013-01-31 | Ligocyte Pharmaceuticals, Inc. | Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions |
SG190418A1 (en) | 2010-12-02 | 2013-07-31 | Oncolytics Biotech Inc | Liquid viral formulations |
ES2630012T3 (en) | 2010-12-02 | 2017-08-17 | Oncolytics Biotech Inc. | Freeze-dried viral formulations |
WO2012103464A2 (en) * | 2011-01-28 | 2012-08-02 | Brian Pulliam | Oral thin film vaccine preparation |
KR20150000389A (en) * | 2011-04-28 | 2015-01-02 | 인터내셔널 메디카 파운데이션 | Liquid vaccine preparations |
EP2747777A4 (en) * | 2011-08-25 | 2015-04-29 | Brian Pulliam | Rotavirus preparations with excess calcium ions and high viscosities that ensure vaccine viability at elevated temperatures |
JP6126684B2 (en) | 2012-04-23 | 2017-05-10 | バハラ バイオテック インターナショナル リミテッド | Novel rotavirus vaccine composition and method for preparing the same |
JP6674944B2 (en) * | 2014-07-18 | 2020-04-01 | エムエスディー ウェルカム トラスト ヒルマン ラボラトリーズ プライベート リミテッドMsd Wellcome Trust Hilleman Laboratories Pvt.Ltd. | Improved thermostable spray-dried rotavirus vaccine formulation and method for producing the same |
BR112017000515A2 (en) * | 2014-07-18 | 2017-11-14 | Msd Wellcome Trust Hilleman Laboratories Pvt Ltd | lyophilization-dried thermostable rotavirus vaccine formulation and process for preparing it |
RU2018126322A (en) * | 2015-12-18 | 2020-01-20 | Мерк Шарп И Доум Корп. | THERMALLY STABLE ROTAVIRAL VACCINE COMPOSITIONS AND WAYS OF THEIR APPLICATION |
GB201602880D0 (en) | 2016-02-18 | 2016-04-06 | Ge Healthcare Uk Ltd | Method and composition for biomolecule stabilization |
MA44557B1 (en) | 2016-06-16 | 2021-11-30 | Bharat Biotech Int Ltd | BUFFER-FREE, ACID-STABLE, LOW-DOSAGE ROTAVIRUS VACCINE |
TWI641725B (en) * | 2016-11-15 | 2018-11-21 | 添鴻科技股份有限公司 | Etching solution for titanium-tungsten alloy |
MX2019008105A (en) | 2017-01-06 | 2020-07-22 | Stabilitech Biopharma Ltd | Virus. |
US10413604B2 (en) | 2017-02-14 | 2019-09-17 | Inventprise, Llc | Heat stable liquid rotavirus vaccine |
US11110163B2 (en) | 2017-02-14 | 2021-09-07 | Inventprise, Llc | Heat stable vaccines |
CN107174663B (en) * | 2017-05-22 | 2020-06-30 | 杭州洪晟生物技术股份有限公司 | Vaccine freeze-drying protective agent |
CN108624505A (en) * | 2018-08-29 | 2018-10-09 | 上海比昂生物医药科技有限公司 | A kind of slow virus freezing drying protective agent and slow virus freeze-dried powder |
CN114392237B (en) * | 2021-12-28 | 2024-02-02 | 上海允英生物医药科技有限公司 | Freeze-dried virus preparation and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5626851A (en) * | 1987-11-30 | 1997-05-06 | The Wistar Institute Of Anatomy And Biology | Rotavirus reassortant vaccine |
US5932223A (en) * | 1996-09-26 | 1999-08-03 | Merck & Co., Inc. | Rotavirus vaccine formulations |
US6403098B1 (en) * | 1996-09-26 | 2002-06-11 | Merck & Co., Inc. | Rotavirus vaccine formulations |
-
2000
- 2000-08-03 US US09/631,807 patent/US6616931B1/en not_active Expired - Fee Related
-
2001
- 2001-07-20 AU AU2001280908A patent/AU2001280908A1/en not_active Abandoned
- 2001-07-20 WO PCT/US2001/023926 patent/WO2002011540A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002011540A1 (en) | 2002-02-14 |
US6616931B1 (en) | 2003-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001280908A1 (en) | Rotavirus vaccine formulations | |
AU2001279972A1 (en) | Pesticidal formulations | |
GB0020953D0 (en) | Vaccine | |
HUP0301043A3 (en) | Vaccine | |
IL155072A0 (en) | Vaccine | |
HUP0301413A3 (en) | Vaccine compositions | |
AU2001258279A1 (en) | Adjuvant for vaccines | |
AU1591402A (en) | Vaccine | |
AU2001267707A1 (en) | Antiperspirant formulations | |
GB0015490D0 (en) | Novel formulations | |
GB0014288D0 (en) | Vaccine | |
AU2002210407A1 (en) | Therapeutic vaccine formulations containing chitosan | |
AU2001267693A1 (en) | Antiperspirant formulations | |
AU6158700A (en) | Vaccine | |
AU2001267541A1 (en) | Vaccine composition | |
GB0026334D0 (en) | Vaccine | |
GB0014845D0 (en) | Vaccine | |
GB0025694D0 (en) | Vaccine | |
AU5811600A (en) | Vaccine | |
AU1101701A (en) | Vaccine compositions | |
GB0003082D0 (en) | Vaccine | |
GB9911823D0 (en) | New vaccine formulations | |
AU2001266534A1 (en) | Papillomavirus vaccine | |
AU3397101A (en) | Adjuvants | |
GB0006693D0 (en) | Vaccine |